Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia

Infant 13-valent pneumococcal conjugate vaccination (PCV13) was introduced to the UK in 2010. Its impact on serotypes implicated in adult non-bacteraemic pneumococcal pneumonia is not known. Beginning in 2008, a 5-year prospective cohort study of adults admitted to hospital with community-acquired p...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The European respiratory journal Ročník 45; číslo 6; s. 1632
Hlavní autori:	Rodrigo, Chamira, Bewick, Thomas, Sheppard, Carmen, Greenwood, Sonia, Mckeever, Tricia M, Trotter, Caroline L, Slack, Mary, George, Robert, Lim, Wei Shen
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 01.06.2015
Predmet:	Aged Aged, 80 and over Cohort Studies Community-Acquired Infections - epidemiology Community-Acquired Infections - prevention & control Female Hospitalization - trends Humans Incidence Male Middle Aged Pneumococcal Vaccines - therapeutic use Pneumonia, Pneumococcal - epidemiology Pneumonia, Pneumococcal - microbiology Pneumonia, Pneumococcal - prevention & control Prospective Studies Serogroup Streptococcus pneumoniae - isolation & purification
ISSN:	1399-3003, 1399-3003
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!